Publicacións en colaboración con investigadores/as de University of Washington (2)

2023

  1. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

    European Journal of Cancer, Vol. 185, pp. 105-118

2022

  1. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

    The Lancet Oncology, Vol. 23, Núm. 3, pp. 362-373